Randomized Evaluation of Operating Room Extubation After Cardiac Surgery
Cardiac Surgery
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 120 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
We are studying whether waking patients up and removing the breathing tube (also known as "extubation") in the operating room after cardiac surgery improves postoperative recovery without causing harm.
Read the full description
This is a pragmatic, randomized controlled trial comparing OR extubation versus ICU extubation among adults undergoing elective cardiac surgery.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- Adults (age 18+) scheduled for elective cardiac surgery requiring cardiopulmonary bypass
- Low perioperative risk defined as STS Predicted Risk of Mortality (PROM) ≤ 3% based on the latest STS Adult Cardiac Surgery Database (ACSD) Risk Calculator
- Deemed appropriate for OR extubation preoperatively by the attending cardiac surgeon
- Able to provide informed consent
Exclusion Criteria:
- Underlying pulmonary disease requiring use of home supplemental oxygen
- Pre-capillary pulmonary hypertension (mPAP ≥ 25 mmHg or PVR \> 2 Wood units) on most recent right heart catheterization for any patient for which there is suspicion for pulmonary hypertension at the time of preoperative evaluation
- Preoperative right ventricular dysfunction greater than mild on most recent echocardiogram
- BMI ≥ 35
- Obstructive sleep apnea with home CPAP or biPAP use or recommended use
- Neuromuscular disease associated with respiratory muscle weakness including myasthenia gravis, Lambert-Eaton myasthenic syndrome, or muscular dystrophy
- Airway abnormalities including tracheostomy, history of difficult mask ventilation, history of difficult intubation requiring fiberoptic rescue or multiple (\>2) attempts, known anatomic abnormalities including limited mouth opening (\< 3cm), severe micrognathia, tracheal stenosis, or tracheal compression due to mass or goiter
We will also exclude patients undergoing the following procedures:
- Transplant surgery
- Pulmonary thromboendarterectomy
- Implantation of mechanical circulatory support including LVAD, Impella, intra-aortic balloon pump, RVAD, or ECMO
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Double masked
OR extubation
Extubation in the operating room (OR) at the conclusion of cardiac surgery
Procedure: OR extubation
ICU extubation
Extubation in the intensive care unit (ICU) within 6 hours of leaving the OR
Procedure: ICU extubation
OR extubation PROCEDURE
Immediate extubation in the operating room (OR) at the conclusion of cardiac surgery
ICU extubation PROCEDURE
Extubation in the intensive care unit (ICU) within 6 hours of leaving the operating room after cardiac surgery
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Hierarchical composite endpoint, ordered by clinical priority
Time frame: 15 days postoperatively
1. Death by postoperative day 15;
2. Unplanned reintubation or cumulative mechanical ventilation \> 12 hours from OR exit, assessed through 48 hours postoperatively;
3. Days at home through postoperative day 15 (DAH-15). DAH-15 will be measured from the time of post-operative ICU admission and will subtract any time spent in a hospital (index hospitalization or readmission), rehabilitation center, or nursing facility.
Secondary measures
Postoperative ICU length of stay
Time frame: 30 days
Cumulative length of stay (hours) in an intensive care unit (ICU) following cardiac surgery
Postoperative hospital length of stay
Time frame: 30 days
Length of index hospitalization (hours) following cardiac surgery
Use of non-invasive respiratory support
Time frame: 48 hours
Use of non-invasive respiratory support such as biPAP, CPAP, or high flow oxygen after OR exit
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (2)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
2 locations
Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Brigham and Women's HospitalBoston, Massachusetts, United StatesNot yet recruiting
Study team and timeline
- Lead sponsor
- Massachusetts General Hospital
- Study start
- Nov 9, 2026 Estimated
- Primary completion
- 2027-05 Estimated
- Study completion
- 2027-06 Estimated
- First posted
- Aug 11, 2026 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
Randomized Evaluation of Operating Room Extubation Versus Intensive Care Unit Extubation After Cardiac Surgery
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
